Live
BioPharma DiveArvinas, Pfizer find new partner for ‘Protac’ breast cancer drugFierceBiotechAlphabet's AI biotech Isomorphic Labs bags $2.1B series B to fuel next-gen drug design modelEndpoints NewsFive burning Qs for Isomorphic Labs after $2.1B raise for AI biotechLonza NewsLonza Launches Xcite AAV Producer Cell Line Platform - Contract PharmaEndpoints NewsPfizer and Arvinas give disappointing breast cancer drug to RigelFierceBiotechBoehringer furthers inflammatory expansion with €407M biobucks bet on Immunitas assetEndpoints NewsBayer to make 'careful but aggressive' return to pharma M&A, CEO saysEndpoints NewsAlkermes' narcolepsy Phase 3 success; Boehringer's antibody dealFierceBiotechAstraZeneca’s $800M bet undermined by immunogenicity in phase 310x Genomics NewsA Look At 10x Genomics (TXG) Valuation After A Strong Year And Recent Share Price Pullback - Yahoo FinancePharmaVoiceHow tough is it getting for vaccine makers in the U.S.?FDA News ReleasesFDA Finalizes Food Chemical Safety Post-Market Assessment Program, Launches Reassessment of BHT, ADA

Archive

Latest Oldest
Total 10866
Page 408 / 604
Query --